Please login to the form below

Not currently logged in
Email:
Password:

Jorge Mestre-Ferrandiz to lead Office of Health Economics' consultancy division

Takes on newly-created position as OHE Consulting seeks expansion

Jorge Mestre-Ferrandiz - Office Health EconomicsThe Office of Health Economics (OHE) has appointed Dr Jorge Mestre-Ferrandiz as the first director of OHE Consulting – the organisation's consultancy division.

Mestre-Ferrandiz will lead the division's efforts to provide research-led consultancy in the health and life sciences economics and policy as it attempts to win external funding as part of plans to expand its operations.

He is in the sixth year of his second spell with the OHE, having previously worked at the research firm from 2001 to 2005 before spending a year at Spanish pharmaceutical trade association Farmaindustria.

He moved back to UK-based OHE in 2006, however, rejoining as a senior economist. In his new role Mestre-Ferrandiz will be responsible for all aspects of the OHE's consultancy business, including marketing, business development and project management.

He will also continue to contribute to all other OHE activities, including advising the UK pharma body the ABPI, as well as conducting and publishing his own research.

Mestre-Ferrandiz said: “I am confident that our experienced and highly skilled team of health economists will be a great draw for those looking to further their understanding of the health and life-sciences landscape and I am pleased I will be still be contributing personally as an economist to on-going projects.”

OHE Consultancy was set up in 2002 as an offshoot of the 50-year old OHE, which is funded by research grants and consultancy revenues from sources such as the ABPI, Department of Health, National Institute of Health Research and Medical Research Council.

17th July 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics